Diabetes Clinical Trials

Showing 3461-3480 of 7,874 trials

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

NCT03457012

The purpose of the study is to collect information on how semaglutide works in real world patients. Participants will get semaglutide prescribed by the study doctor. The study will last for about 6 to 8 months. Participants will be asked to complete some questionnaires about the health and the diabetes treatment. Participants will complete these during the normally scheduled visits with the study doctor.

Diabetes Mellitus, Type 2

Novo Nordisk A/S462 participantsStarted Mar 2018

Cambridge, Ontario, Canada

COMPLETEDPhase 3

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

NCT04510493

The purpose of this study is to evaluate whether Canakinumab has beneficial effects on patients with Type 2 diabetes mellitus and coronavirus disease 19 (COVID19).

Coronavirus InfectionDiabetes Mellitus, Type 2

University Hospital, Basel, Switzerland116 participantsStarted Oct 2020

Aarau, Switzerland • Basel, Switzerland • Bern, Switzerland +6 more locations

UNKNOWNNA

Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG & SMM

NCT04058730

A Comparative Interventional Study to Evaluate the Role of Laparoscopic Roux-en-Y Gastric Bypass (LRYGBP), Laparoscopic Sleeve Gastrectomy (LSG) and Standard Medical Management (SMM) in Patients of Type II Diabetes Mellitus (DM) and Body Mass Index ( BMI) Between 27.5 - 32.5 kg / m²."

Type 2 Diabetes Mellitus

Max Institute of Minimally Access, Metabolic & Bariatric Surgery150 participantsStarted Apr 2015

New Delhi, India • New Delhi, India

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG & SMM

Related Searches

Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium

Effect of F. Prausnitzii on Glycemic Control

Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes.

Evaluation of Extended Wear Infusion Set With 670G Hybrid Closed-Loop Therapy

iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes

Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM

NAFLD Among Patients With Type 2 Diabetes and CKD

Effectiveness and Cost-effectiveness of a Telemonitoring Program for Diabetic People at Home

A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes

Study to Evaluate a Prototype Non-Invasive BG Measurement System

Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique

Effectiveness of The Health Care CEO App for T1D

Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects